Efficacy and Safety of Sofosbuvir Plus Ribavirin in Japanese Adults With Chronic Genotype 2 HCV Infection
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the antiviral efficacy, safety, and tolerability of sofosbuvir (SOF)
plus ribavirin (RBV) in Japanese participants with chronic genotype 2 hepatitis C virus (HCV)
infection.